Literature DB >> 8620564

Mono- and dimethylation of arsenic in rat liver cytosol in vitro.

M Styblo1, M Delnomdedieu, D J Thomas.   

Abstract

Production of methylarsonate and dimethylarsinate from radiolabelled [73 As]arsenite and [73 As]arsenate was examined in an assay system that contained cytosol prepared from a 20% homogenate (w/v) of livers from 8- 10-week-old male Fischer 344 rats. After a 60-min incubation at 37 degrees C with added S-adenosylmethionine and glutathione, up to 50% of carrier-free [73As]arsenite and about 15% of carrier-free [73As]arsenate were methylated. Incubation of cytosol at 100% degrees C for 1 min before addition to the assay system completely abolished methylation of arsenite. Production of methylarsonate increased in proportion to the arsenite concentration in the assay system; however, 50 microM arsenite inhibited production of dimethylarsinate. Methylarsonate production from carrier-free [73-As]arsenite was not dependent on addition of exogenous S-adenosylmethionine to the assay system. Addition of 0.1 mM S-adenosylmethionine maximized dimethylarsinate production. Addition of 0.1 or 1.0 mM S-adenosylhomocysteine decreased methylation of arsenite, especially dimethylarsinate production. Omission of glutathione from the assay system nearly abolished the methylation of arsenite. Addition of exogenous glutathione to the assay system (up to 20 mM) decreased protein binding of arsenic and increased the production of methylarsonate and dimethylarsinate. The effects of sodium selenite, mercuric chloride, EDTA, p-anisic acid and 2,3-dichloro-alpha-methylbenzylamine on the methylation of arsenite were determined. Addition of 10 microM selenite to the assay system nearly abolished the formation of either methylated species. Addition of 1 or 10 microM mercuric chloride inhibited dimethylarsinate production in a concentration-dependent manner but had little effect on methylarsonate yield. Addition of 10 mM EDTA to the assay system inhibited formation of both methylated metabolites, suggesting that an endogenous divalent cation might be involved in enzymatic methylation of arsenic. Neither p-anisic acid, an inhibitor of cytosolic methyltransferases, nor 2,3-dichloro-alpha-methylbenzylamine, an inhibitor of microsomal methyltransferases, inhibited the conversion of inorganic arsenic to mono- or dimethylated metabolites.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8620564     DOI: 10.1016/0009-2797(95)03666-0

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  16 in total

Review 1.  Microbial methylation of metalloids: arsenic, antimony, and bismuth.

Authors:  Ronald Bentley; Thomas G Chasteen
Journal:  Microbiol Mol Biol Rev       Date:  2002-06       Impact factor: 11.056

Review 2.  Arsenic (+3 oxidation state) methyltransferase and the methylation of arsenicals.

Authors:  David J Thomas; Jiaxin Li; Stephen B Waters; Weibing Xing; Blakely M Adair; Zuzana Drobna; Vicenta Devesa; Miroslav Styblo
Journal:  Exp Biol Med (Maywood)       Date:  2007-01

3.  In vitro assays of inorganic arsenic methylation.

Authors:  Zuzana Drobna; Miroslav Styblo; David J Thomas
Journal:  Curr Protoc Toxicol       Date:  2009-11

4.  Alteration of mammary gland development and gene expression by in utero exposure to arsenic.

Authors:  Daniela A Parodi; Morgan Greenfield; Claire Evans; Anna Chichura; Alexandra Alpaugh; James Williams; Mary Beth Martin
Journal:  Reprod Toxicol       Date:  2014-12-25       Impact factor: 3.143

5.  Pharmacokinetic modeling of arsenite uptake and metabolism in hepatocytes--mechanistic insights and implications for further experiments.

Authors:  Michael R Easterling; Miroslav Styblo; Marina V Evans; Elaina M Kenyon
Journal:  J Pharmacokinet Pharmacodyn       Date:  2002-06       Impact factor: 2.745

6.  Development of a human physiologically based pharmacokinetic (PBPK) model for inorganic arsenic and its mono- and di-methylated metabolites.

Authors:  Hisham A El-Masri; Elaina M Kenyon
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-10-18       Impact factor: 2.745

7.  Effects of selenium on the structure and function of recombinant human S-adenosyl-L-methionine dependent arsenic (+3 oxidation state) methyltransferase in E. coli.

Authors:  Zhirong Geng; Xiaoli Song; Zhi Xing; Jinlong Geng; Sichun Zhang; Xinrong Zhang; Zhilin Wang
Journal:  J Biol Inorg Chem       Date:  2009-01-22       Impact factor: 3.358

Review 8.  Origins, fate, and actions of methylated trivalent metabolites of inorganic arsenic: progress and prospects.

Authors:  Miroslav Stýblo; Abhishek Venkatratnam; Rebecca C Fry; David J Thomas
Journal:  Arch Toxicol       Date:  2021-03-26       Impact factor: 5.153

Review 9.  Arsenic binding to proteins.

Authors:  Shengwen Shen; Xing-Fang Li; William R Cullen; Michael Weinfeld; X Chris Le
Journal:  Chem Rev       Date:  2013-06-28       Impact factor: 60.622

10.  Arsenic speciation in saliva of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment.

Authors:  Baowei Chen; Fenglin Cao; Chungang Yuan; Xiufen Lu; Shengwen Shen; Jin Zhou; X Chris Le
Journal:  Anal Bioanal Chem       Date:  2013-01-15       Impact factor: 4.142

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.